ArticleIndian journal of endocrinology and metabolism
Evaluation of Serum Irisin Levels in Individuals with Gender Incongruence and Its Metabolic Correlations.
Article in Indian journal of endocrinology and metabolism. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Transgender Health: A Metabolic Wake-Up Call.Indian journal of endocrinology and metabolismArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Irisin, a myokine implicated in energy homeostasis, has been proposed as a biomarker for metabolic dysfunction. This study aimed to assess serum irisin levels and their associations with metabolic parameters in gender-incongruent individuals compared to healthy cisgender controls and to assess the predictive value of irisin and related metabolic indices for metabolic syndrome (MetS) using both affirmed and birth-assigned gender criteria. Methods: A cross-sectional "observational, non-randomised" study was conducted from June 2024 to February 2025 among 123 participants (transgender women, transgender men, cisgender women and cisgender men), matched for age and body mass index. Individuals with confounding metabolic conditions were excluded. Serum irisin was measured using a sandwich enzyme-linked immunosorbent assay, and metabolic parameters were evaluated. Statistical analyses assessed the diagnostic utility of irisin and various metabolic indices for MetS. Results: In transgender women, serum irisin showed inverse correlation with diastolic blood pressure ( Conclusion: Serum irisin is associated with select metabolic parameters but has limited utility in predicting MetS in gender incongruent individuals. Affirmed gender-based assessment enhances risk stratification, with Ty/HDL and Ty/G indices offering better predictive value in transgender populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.